Test Price
2,800 AED✅ Home Collection Available
SFTPD Gene Sequencing Test for Surfactant Metabolism Dysfunction in UAE | 2800 AED | DNA Labs UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited next‑generation sequencing and bioinformatics pipeline.
- Premium Logistics: VIP mobile phlebotomy and temperature‑controlled cold‑chain home collection for whole blood, extracted DNA, or FTA card specimens, available daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary post‑test genetic counselling and telephonic clinical result interpretation by a DHA‑licensed Consultant Medical Geneticist.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
- Turnaround Time: 21–28 calendar days with expedited processing available upon request.
Test Overview & Methodology
The SFTPD NGS test sequences the entire coding region of the surfactant protein D gene to identify pathogenic variants linked to surfactant metabolism dysfunction, a rare neonatal‑onset interstitial lung disease. This assay delivers a definitive molecular diagnosis that guides targeted respiratory management, family planning, and eligibility for emerging precision therapies. The methodology employs next‑generation sequencing on an Illumina platform with orthogonal Sanger confirmation for all clinically actionable variants. Bioinformatic analysis follows ACMG/AMP variant interpretation guidelines and is cross‑referenced against population‑specific allele frequency databases relevant to the UAE demographic.
| Feature | Our Test (DHA‑Accredited Lab) | Closest Alternative (Overseas Shipment) |
|---|---|---|
| Methodology | NGS (Next-Generation Sequencing) + Sanger confirmation | NGS or exome panel without UAE‑specific variant interpretation |
| Turnaround Time | 3–4 weeks (expedited option available) | 4–8 weeks, plus customs delay |
| Clinical Report | DHA‑standardized, includes ACMG classification & genetic counselling note | Generic report, may lack local regulatory annotations |
| Sample Options | Whole blood, extracted DNA, or dried blood spot on FTA card | Often requires whole blood only |
Physician Insight & Safety Protocols
“Genetic testing for surfactant metabolism dysfunction provides critical diagnostic clarity in neonatal respiratory distress. A negative SFTPD result does not exclude variants in other surfactant genes such as SFTPB, SFTPC, or ABCA3; therefore, clinical correlation with high‑resolution CT imaging and lung biopsy histopathology remains essential. Our multidisciplinary team ensures that every result is contextualised within the full clinical picture, and families receive compassionate, culturally sensitive guidance throughout the diagnostic journey.”
– Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
Medication Advisory
⚠️ Important Medication Advisory
Do not discontinue or adjust prescribed respiratory medications (including corticosteroids, bronchodilators, or diuretics) without consulting your managing physician. This genetic test is a diagnostic adjunct and does not replace ongoing clinical monitoring or treatment. Continue all current therapies as directed by your healthcare provider.
Patient Safety – Exclusion Criteria & Emergency Indicators
- Active febrile illness (temperature ≥38.5°C) or untreated systemic infection – postpone sample collection.
- Severe bleeding diathesis or platelet count <50,000/µL – obtain medical clearance before venipuncture.
- Concurrent anticoagulant therapy that cannot be temporarily held; discuss risk with the referring physician.
- Seek immediate emergency care (call 998) if the affected infant demonstrates: grunting, chest retractions, perioral cyanosis, or oxygen saturation below 90% on prescribed home oxygen.
- For acute deterioration after sample collection, contact your paediatric pulmonologist or proceed directly to the nearest emergency department.
Patient FAQ & Clinical Guidance
1. What is the SFTPD gene test and how does it guide my child’s respiratory treatment?
Snippet answer: The SFTPD test identifies pathogenic mutations that cause surfactant protein D deficiency. A positive result enables neonatologists to tailor ventilator strategies, optimise surfactant replacement therapy, and evaluate eligibility for precision medicine clinical trials targeting the surfactant pathway.
2. How long do results take and will a genetic counsellor explain the report?
Snippet answer: Final reports are delivered within 21 to 28 calendar days. A complimentary 20‑minute genetic counselling session (conducted in English or Arabic) is automatically scheduled upon result release to ensure complete understanding of the clinical implications.
3. Is home sample collection safe and does my UAE health insurance cover the test?
Snippet answer: Yes – our ISO‑certified phlebotomists follow strict temperature‑controlled cold‑chain protocols for all home visits. We verify direct billing eligibility with major UAE insurers via WhatsApp prior to scheduling, so you receive full cost transparency upfront.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Security: All patient genetic data is processed and stored in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Specimen handling, result reporting, and clinical correspondence are governed by the confidentiality and consent provisions of Federal Decree-Law No. 4 of 2016 on Medical Liability.
Laboratory Certification: ISO 9001:2015 Certified Laboratory (Cert: INT/EGQ/2509DA/3139) | DHA Facility License: 1143
Support & Appointment Scheduling: WhatsApp +971 54 548 8731
Clinical & Logistical Metadata
| Test Name | SFTPD Gene Sequencing for Surfactant Metabolism Dysfunction |
| Price (AED) | 2,800 AED |
| Turnaround Time | 21–28 calendar days |
| Sample Type / Matrix | Whole blood (EDTA), extracted DNA, or dried blood spot on FTA card |
| Methodology Used | Next-Generation Sequencing (NGS) with Sanger confirmation |
| ICD-10-CM Code | J84.89 |
| LOINC Code | 97648-4 |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians